Gritstone Bio - 53 Year Dividend History | GRTS
Historical dividend payout and yield for Gritstone Bio (GRTS) since 1971. The current TTM dividend payout for Gritstone Bio (GRTS) as of April 24, 2024 is $0.00. The current dividend yield for Gritstone Bio as of April 24, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.072B |
$0.016B |
|
Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars - first, a proprietary machine learning-based platform, Gritstone EDGE(TM), which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient?s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients? TSNA to drive the patient?s immune system to attack and destroy tumors.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
